Cargando…

Interactions between amphibians' symbiotic bacteria cause the production of emergent anti-fungal metabolites

Amphibians possess beneficial skin bacteria that protect against the disease chytridiomycosis by producing secondary metabolites that inhibit the pathogen Batrachochytrium dendrobatidis (Bd). Metabolite production may be a mechanism of competition between bacterial species that results in host prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Loudon, Andrew H., Holland, Jessica A., Umile, Thomas P., Burzynski, Elizabeth A., Minbiole, Kevin P. C., Harris, Reid N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139739/
https://www.ncbi.nlm.nih.gov/pubmed/25191317
http://dx.doi.org/10.3389/fmicb.2014.00441
_version_ 1782331403911823360
author Loudon, Andrew H.
Holland, Jessica A.
Umile, Thomas P.
Burzynski, Elizabeth A.
Minbiole, Kevin P. C.
Harris, Reid N.
author_facet Loudon, Andrew H.
Holland, Jessica A.
Umile, Thomas P.
Burzynski, Elizabeth A.
Minbiole, Kevin P. C.
Harris, Reid N.
author_sort Loudon, Andrew H.
collection PubMed
description Amphibians possess beneficial skin bacteria that protect against the disease chytridiomycosis by producing secondary metabolites that inhibit the pathogen Batrachochytrium dendrobatidis (Bd). Metabolite production may be a mechanism of competition between bacterial species that results in host protection as a by-product. We expect that some co-cultures of bacterial species or strains will result in greater Bd inhibition than mono-cultures. To test this, we cultured four bacterial isolates (Bacillus sp., Janthinobacterium sp., Pseudomonas sp. and Chitinophaga arvensicola) from red-backed salamanders (Plethodon cinereus) and cultured isolates both alone and together to collect their cell-free supernatants (CFS). We challenged Bd with CFSs from four bacterial species in varying combinations. This resulted in three experimental treatments: (1) CFSs of single isolates; (2) combined CFSs of two isolates; and (3) CFSs from co-cultures. Pair-wise combinations of four bacterial isolates CFSs were assayed against Bd and revealed additive Bd inhibition in 42.2% of trials, synergistic inhibition in 42.2% and no effect in 16.6% of trials. When bacteria isolates were grown in co-cultures, complete Bd inhibition was generally observed, and synergistic inhibition occurred in four out of six trials. A metabolite profile of the most potent co-culture, Bacillus sp. and Chitinophaga arvensicola, was determined with LC-MS and compared with the profiles of each isolate in mono-culture. Emergent metabolites appearing in the co-culture were inhibitory to Bd, and the most potent inhibitor was identified as tryptophol. Thus mono-cultures of bacteria cultured from red-backed salamanders interacted synergistically and additively to inhibit Bd, and such bacteria produced emergent metabolites when cultured together, with even greater pathogen inhibition. Knowledge of how bacterial species interact to inhibit Bd can be used to select probiotics to provide amphibians with protection against Bd.
format Online
Article
Text
id pubmed-4139739
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-41397392014-09-04 Interactions between amphibians' symbiotic bacteria cause the production of emergent anti-fungal metabolites Loudon, Andrew H. Holland, Jessica A. Umile, Thomas P. Burzynski, Elizabeth A. Minbiole, Kevin P. C. Harris, Reid N. Front Microbiol Microbiology Amphibians possess beneficial skin bacteria that protect against the disease chytridiomycosis by producing secondary metabolites that inhibit the pathogen Batrachochytrium dendrobatidis (Bd). Metabolite production may be a mechanism of competition between bacterial species that results in host protection as a by-product. We expect that some co-cultures of bacterial species or strains will result in greater Bd inhibition than mono-cultures. To test this, we cultured four bacterial isolates (Bacillus sp., Janthinobacterium sp., Pseudomonas sp. and Chitinophaga arvensicola) from red-backed salamanders (Plethodon cinereus) and cultured isolates both alone and together to collect their cell-free supernatants (CFS). We challenged Bd with CFSs from four bacterial species in varying combinations. This resulted in three experimental treatments: (1) CFSs of single isolates; (2) combined CFSs of two isolates; and (3) CFSs from co-cultures. Pair-wise combinations of four bacterial isolates CFSs were assayed against Bd and revealed additive Bd inhibition in 42.2% of trials, synergistic inhibition in 42.2% and no effect in 16.6% of trials. When bacteria isolates were grown in co-cultures, complete Bd inhibition was generally observed, and synergistic inhibition occurred in four out of six trials. A metabolite profile of the most potent co-culture, Bacillus sp. and Chitinophaga arvensicola, was determined with LC-MS and compared with the profiles of each isolate in mono-culture. Emergent metabolites appearing in the co-culture were inhibitory to Bd, and the most potent inhibitor was identified as tryptophol. Thus mono-cultures of bacteria cultured from red-backed salamanders interacted synergistically and additively to inhibit Bd, and such bacteria produced emergent metabolites when cultured together, with even greater pathogen inhibition. Knowledge of how bacterial species interact to inhibit Bd can be used to select probiotics to provide amphibians with protection against Bd. Frontiers Media S.A. 2014-08-21 /pmc/articles/PMC4139739/ /pubmed/25191317 http://dx.doi.org/10.3389/fmicb.2014.00441 Text en Copyright © 2014 Loudon, Holland, Umile, Burzynski, Minbiole and Harris. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Loudon, Andrew H.
Holland, Jessica A.
Umile, Thomas P.
Burzynski, Elizabeth A.
Minbiole, Kevin P. C.
Harris, Reid N.
Interactions between amphibians' symbiotic bacteria cause the production of emergent anti-fungal metabolites
title Interactions between amphibians' symbiotic bacteria cause the production of emergent anti-fungal metabolites
title_full Interactions between amphibians' symbiotic bacteria cause the production of emergent anti-fungal metabolites
title_fullStr Interactions between amphibians' symbiotic bacteria cause the production of emergent anti-fungal metabolites
title_full_unstemmed Interactions between amphibians' symbiotic bacteria cause the production of emergent anti-fungal metabolites
title_short Interactions between amphibians' symbiotic bacteria cause the production of emergent anti-fungal metabolites
title_sort interactions between amphibians' symbiotic bacteria cause the production of emergent anti-fungal metabolites
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139739/
https://www.ncbi.nlm.nih.gov/pubmed/25191317
http://dx.doi.org/10.3389/fmicb.2014.00441
work_keys_str_mv AT loudonandrewh interactionsbetweenamphibianssymbioticbacteriacausetheproductionofemergentantifungalmetabolites
AT hollandjessicaa interactionsbetweenamphibianssymbioticbacteriacausetheproductionofemergentantifungalmetabolites
AT umilethomasp interactionsbetweenamphibianssymbioticbacteriacausetheproductionofemergentantifungalmetabolites
AT burzynskielizabetha interactionsbetweenamphibianssymbioticbacteriacausetheproductionofemergentantifungalmetabolites
AT minbiolekevinpc interactionsbetweenamphibianssymbioticbacteriacausetheproductionofemergentantifungalmetabolites
AT harrisreidn interactionsbetweenamphibianssymbioticbacteriacausetheproductionofemergentantifungalmetabolites